---
schema_version: "secwatch.filing_event.v1"
accession: "0001773751-23-000027"
form_type: "8-K"
ticker: "HIMS"
cik: "0001773751"
company_name: "Hims & Hers Health, Inc."
filed_at: "2023-02-27T23:59:59+00:00"
generated_at: "2026-06-18T23:52:14.641437+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Hims & Hers Q4 revenue $167.2M (+97% YoY); achieves first positive adjusted EBITDA of $3.9M

## Summary
- Q4 revenue $167.2M, up 97% YoY; full year revenue $526.9M, up 94% YoY.
- Q4 net loss narrowed to $10.9M from $31.2M; adjusted EBITDA positive $3.9M (vs -$7.1M).
- Subscribers surpassed 1M (1.04M), up 88% YoY; monthly online revenue per subscriber $55.
- FY2023 guidance: revenue $735-755M, adjusted EBITDA $20-30M.
- Introduced 2025 targets: at least $1.2B revenue and $100M adjusted EBITDA.

## SEC filing metadata
- accession: 0001773751-23-000027
- form_type: 8-K
- ticker: HIMS
- cik: 0001773751
- company_name: Hims & Hers Health, Inc.
- filed_at: 2023-02-27T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1773751/000177375123000027/0001773751-23-000027-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1773751/000177375123000027/hims-20230227.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001773751-23-000027
- JSON: https://secwatch.observer/filing/0001773751-23-000027.json
- Plain text: https://secwatch.observer/filing/0001773751-23-000027.txt

## Key facts
- Earnings Releases
  Hims & Hers Health, Inc. reported Full Year 2022 results: net income $(65.7) million.
  - Period: Full Year 2022
  - Net income: $(65.7) million
  - Result: reported results
  source text: Full year 2022 revenue of $526.9 million, up 94% year-over-year
  evidence_url: https://www.sec.gov/Archives/edgar/data/1773751/000177375123000027/0001773751-23-000027-index.htm
- Earnings Releases
  Hims & Hers Health, Inc. reported Full Year 2022 results: net income $(65.7) million.
  - Period: Full Year 2022
  - Net income: $(65.7) million
  - Result: reported results
  source text: Net loss was $(65.7) million for the year ended December 31, 2022 compared to $(107.7) million for the year ended December 31, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1773751/000177375123000027/0001773751-23-000027-index.htm
- Earnings Releases
  Hims & Hers Health, Inc. reported Q4 2022 results: revenue $167.2 million, net income $(10.9) million.
  - Period: Q4 2022
  - Revenue: $167.2 million
  - Net income: $(10.9) million
  - Result: reported results
  source text: Q4 2022 record revenue of $167.2 million, up 97% year-over-year Q4 2022 net loss of $10.9 million and achieves Adjusted EBITDA profitability of $3.9 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1773751/000177375123000027/0001773751-23-000027-index.htm
- Earnings Releases
  Hims & Hers Health, Inc. reported Full Year 2023 results: revenue $735 million to $755 million. Guidance initiated.
  - Period: Full Year 2023
  - Revenue: $735 million to $755 million
  - Guidance: initiated
  - Result: guidance update
  source text: Provides Q1 and full year 2023 guidance, with full year 2023 revenue in the range of $735 million to $755 million and Adjusted EBITDA in the range of $20 million to $30 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1773751/000177375123000027/0001773751-23-000027-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.